Detalhe da pesquisa
1.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 491-503, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272513
2.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol
; 23(10): 1274-1286, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108662
3.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129443
4.
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Cochrane Database Syst Rev
; (3): CD011430, 2015 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25730344
5.
Mediastinal staging of lung cancer: novel concepts.
Lancet Oncol
; 13(5): e221-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22554550
6.
Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A systematic literature review and meta-analysis.
Lung Cancer
; 174: 174-185, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717343
7.
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
J Thorac Oncol
; 16(6): 960-967, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539971
8.
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
JAMA Oncol
; 2021 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34086039
9.
Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.
Respir Res
; 10: 86, 2009 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19781081
10.
Diagnosis of palmar hyperhidrosis via questionnaire without physical examination.
Clin Auton Res
; 19(3): 175-81, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19370373
11.
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Thorac Oncol
; 14(1): 124-129, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30138764
12.
Intraoperative staging and surgical management of stage IIIA/N2 non-small cell lung cancer.
Thorac Surg Clin
; 18(4): 381-91, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19086607
13.
Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.
Lung Cancer
; 56(1): 97-103, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239984
14.
Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer.
Nucl Med Commun
; 28(3): 173-7, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17264775
15.
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer-Reply.
JAMA Oncol
; 8(1): 168-169, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34734971
16.
18F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 97(2): 372-380, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28068244
17.
Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design.
Int J Radiat Oncol Biol Phys
; 94(4): 738-46, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26972646
18.
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
Lung Cancer
; 48(3): 389-97, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15893008
19.
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer.
Lung Cancer
; 87(1): 23-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468149
20.
Indirect measurements of differential gene expression with cDNA microarrays.
Biotechniques
; 36(2): 310-4, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14989096